The role of novel risk-scoring systems in predicting the efficacy of immunotherapy
Background. Metastatic non-small cell lung cancer (mNSCLC) remains a significant oncological challenge despite major advancements in treatment with immune checkpoint inhibitors (ICIs). However, some patients resist ICIs, highlighting the need for novel risk-scoring systems to predict immunotherapy e...
Saved in:
| Main Author: | Yu.V. Moskalenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
V. N. Karazin Kharkiv National University
2025-02-01
|
| Series: | Journal of V. N. Karazin Kharkiv National University: Series Medicine |
| Subjects: | |
| Online Access: | https://ukrmedsci.com/index.php/visnyk/article/view/139 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel model for predicting immunotherapy response and prognosis in NSCLC patients
by: Ting Zang, et al.
Published: (2025-05-01) -
Inflammatory markers predict efficacy of immunotherapy in advanced non-small cell lung cancer: a preliminary exploratory study
by: Yingqing Zhang, et al.
Published: (2025-01-01) -
Multi-omics analysis reveals the sensitivity of immunotherapy for unresectable non-small cell lung cancer
by: Rui Wu, et al.
Published: (2025-02-01) -
Baseline 18F-FDG PET/CT parameters in predicting the efficacy of immunotherapy in non-small cell lung cancer
by: Lu Zheng, et al.
Published: (2025-01-01) -
Liquid biopsy using plasma proteomics in predicting efficacy and tolerance of PD-1/PD-L1 blockades in NSCLC: a prospective exploratory study
by: Yuan Gao, et al.
Published: (2025-07-01)